CCL20 and ovarian carcinoma: Our first correlational experiment revealed that p53-null or mutated ovarian cancer cells highly expressed proinflammatory chemokines such as CCL20, CCL28, CXCL1, 2, 3 and 8 which agrees with our previous observations [10].